Could cord blood be the key to soothing dry eyes?

NCT ID NCT07089511

Completed Symptom relief Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study is testing whether eye drops made from cord blood plasma can relieve symptoms of moderate to severe dry eye disease better than standard artificial tears. Researchers will compare the cord blood drops combined with cyclosporine to a control treatment of hyaluronic acid and cyclosporine. The trial aims to enroll 100 adults with dry eye and will measure changes in corneal staining after two months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cord blood platelet poor plasma eye drops
What this could lead to: If it works, this could offer a more effective option for people with moderate to severe dry eye that doesn't respond well to artificial tears.
What could go wrong: This is a small, early-stage trial comparing two treatments, so results may not be conclusive. The cord blood drops are experimental and may not work better than the standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE

Contacts and locations

Locations

Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico

Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.